Fierce JPM Week: 5 industry execs discuss pandemic supply chain issues, solutions
How have companies adapted to supply chain challenges posed by the coronavirus pandemic? In a panel discussion during Fierce JPM Week, five industry executives considered supply chain issues and solutions.(Questex)
In discussing how the pharma industry has adjusted to the supply chain issues brought on by the coronavirus pandemic, Catalent president and chief operating officer Alessandro Maselli invoked the words of Winston Churchill.
“Never let a good crisis go to waste,” Churchill famously said as he was helping form the United Nations following World War II.
Judging from a recent Fierce JPM Week panel discussion, which included Maselli and four other industry executives, companies are definitely not letting this pandemic go to waste as they quickly adapt their strategies based on lessons learned over the last two years.
Joining in the discussion were Al Boyle, Alnylam’s chief technical operations and quality officer; Som Chattopadhyay, Amgen’s vice president global supply chain; Kevin Cook, Sandoz’s vice president supply chain, North America and Holger Weintritt, Bayer’s head of product supply.
Supply chain resilience has long been a source of concern for Amgen, Chattopadhyay said, because of its size as a $25 billion company compared to its relatively small manufacturing footprint. Its largest facility, which is in Puerto Rico, employs
